ArticleiScience2026
Mapping human microglial morphological diversity via handcrafted and deep learning-derived image features.
Article in iScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Microglia regulate brain health and disease through diverse, dynamic activation states, but capturing this continuous heterogeneity at scale remains challenging. We developed an imaging and analysis framework to map activation landscapes of human iPSC-derived microglia (iMG) at single-cell resolution. High-content imaging combined a hypothesis-driven immunofluorescence (IF) panel targeting NF-κB, ASC, and CD45 with a discovery-oriented cell painting (CP) assay. Phenotypes were quantified using handcrafted and representation-learning features. To classify cells, we applied Gaussian mixture models (GMMs), enabling soft probabilistic assignments that capture transitional states. Compared with graph-based methods such as Leiden, GMMs achieved similar performance while providing more interpretable descriptions of microglial heterogeneity. Deep-learning features from the targeted IF panel were most informative, yielding high classification accuracy and strong correlation with biological readouts, including NLRP3 inflammasome activation. This platform offers a scalable approach to quantify microglial states and provides a scalable platform for discovering compounds that modulate microglial phenotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.